Haleon, the consumer health business spun off from GSK last year, has announced the appointment of Michael Durkin as its new Sales Director for Great Britain.
Durkin has been with the business since the start of his career in 2011, working in various sales and marketing roles. He most recently held the position of Marketing Lead Oral Health for Great Britain & Ireland at Haleon, delivering a full commercial strategic overview of the company’s oral health portfolio and setting a comprehensive three-year growth framework for its brands.
Bas Vorsteveld, the group’s General Manager GBI, said: “I am pleased to have Michael leading the Haleon GB Sales operations, an integral role in our business. He brings outstanding experience and an incredible track record in sales and marketing, growing categories and brands currently at Haleon and formerly at GSK Consumer Healthcare. I’m convinced that Mike will continue to be a trusted partner for our customers moving forward and build upon our existing strong partnership.”
Durkin added: “Haleon has a fantastic portfolio of brands, coupled with a clear purpose: to deliver better everyday health, with humanity. I’m proud to be part of the business and to continue to build my career here. I am looking forward to leading the sales function and working with our customers to unlock growth in the GB market and develop our vision for self-care, partnering to deliver environments & experiences that support our consumers to confidently engage in managing their health.”
